Concepedia

Yvette Robbins

YR

Statistics

Publications

21

Citations

1.4K

H-Index

16

Active since

2017

Affiliations

National Cancer Institute(Current)

National Institute on Deafness and Other Communication Disorders

National Institutes of Health

Center for Cancer Research

Johns Hopkins Medicine

Yvette Robbins is an author at National Cancer Institute specializing in oncology, immunotherapy, and immunology.

ORCID

Publications per year

2017–2024

21

Publications

21

Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models

Sarah Greene, Yvette Robbins, Wojciech K. Mydlarz et al. · Clinical Cancer Research · 2019 · 270 citations · Full text

, , +16

Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy

Lillian Sun, Paúl E. Clavijo, Yvette Robbins et al. · JCI Insight · 2019 · 232 citations · Full text

, , +17

PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations

Kellsye P. Fabian, Michelle R. Padget, Renee N. Donahue et al. · Journal for ImmunoTherapy of Cancer · 2020 · 149 citations · Full text

, , +17

γδ T Cells Are Required for the Induction of Sterile Immunity during Irradiated Sporozoite Vaccinations

Irfan Zaidi, Hama Diallo, Solomon Conteh et al. · The Journal of Immunology · 2017 · 115 citations

, , +17

Neoadjuvant PD-1 Immune Checkpoint Blockade Reverses Functional Immunodominance among Tumor Antigen–Specific T Cells

Jay Friedman, Ellen Moore, Paul Zolkind et al. · Clinical Cancer Research · 2019 · 85 citations · Full text

, , +17

1–5 of 21